![](/img/cover-not-exists.png)
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy
M. N. Vo, M. Evans, K. Leitzel, S. M. Ali, M. Wilson, L. Demers, D. B. Evans, A. LiptonVolume:
119
Language:
english
Pages:
5
DOI:
10.1007/s10549-008-0261-5
Date:
February, 2010
File:
PDF, 193 KB
english, 2010